Furulund, Sweden

Johan Sundelin


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1997-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Johan Sundelin: Innovator in Receptor Technology

Introduction

Johan Sundelin is a notable inventor based in Furulund, Sweden. He has made significant contributions to the field of receptor technology, holding a total of 8 patents. His work primarily focuses on the C140 receptor, which has implications in various biological assays and therapeutic developments.

Latest Patents

One of Sundelin's latest patents involves the recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor. The nucleic acid molecules encoding the C140 cell surface receptor have been cloned and sequenced. The availability of C140 receptor DNA allows for the recombinant production of the C140 receptor, which can be expressed on the surface of a cell, including an oocyte. These nucleic acid molecules are instrumental in assays designed to detect substances that influence C140 receptor activity, whether they are receptor agonists or antagonists. Furthermore, the elucidation of the C140 receptor's structure enables the design of specific agonist and antagonist compounds useful in such assays. The availability of the C140 receptor also facilitates the production of antibodies that are specifically immunoreactive with one or more antigenic epitopes of the C140 receptor.

Career Highlights

Throughout his career, Johan Sundelin has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Cor Therapeutics, Inc. and Millennium Pharmaceuticals Limited. His experience in these organizations has contributed to his expertise in receptor technology and innovation.

Collaborations

Sundelin has collaborated with various professionals in his field, including Robert M. Scarborough. These partnerships have furthered his research and development efforts in receptor technology.

Conclusion

Johan Sundelin's innovative work in receptor technology, particularly with the C140 receptor, has positioned him as a significant figure in the field. His contributions through patents and collaborations continue to influence advancements in biological assays and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…